Dyne Therapeutics

Dyne Therapeutics

Associate Director, Clinical Operations Study Lead

Waltham, MA · Director

Sponsorship not specified$165k-$200kDetected 41 days ago
GCPForecastingProcess ImprovementClinical TrialsAnimal StudiesCommunicationProblem SolvingMentoring

Stay score

odds of building a lasting career here

59Sponsors, lottery-bound
Cap-exempt (no lottery)0
Sponsors this role80
Entry-level history0
PERM / green-card track0
Lottery odds (Level IV)94
Fits your clock70

Sponsors, but it's cap-subject — you still face the weighted lottery (~61% per draw at Level IV). Good if you win; have a cap-exempt backup on your list.

Lottery odds assume a STEM candidate.

Personalize to your clock →

H-1B wage level

the lottery is wage-weighted — each level is one more entry

Level I · 1×
Level I$175,8641 entry
Level II$217,7762 entries
Level III$259,6673 entries
Level IV$301,5794 entries

The bottom of this range ($165,000) is below the Level I prevailing wage of $175,864. An H-1B cannot be filed below the prevailing wage, so an offer at the floor of this band could not be sponsored as posted.

DOL prevailing wage, 2026-27 wage year · Natural Sciences Managers (11-9121) · Boston-Cambridge-Newton, MA-NH. Wage level is derived by USCIS from the offered wage, occupation and worksite; the occupation shown is inferred from the job title.

Employer immigration record

from this employer's Department of Labor filings

Files H-1B transfers

2 transfer filings in the last year, covering 2 workers. Median labor-condition decision: 8 days. An employer that already files transfers is one that can take over an existing H-1B.

Sourced from Department of Labor LCA, PERM and prevailing-wage disclosure data. Employer matching is by name, so figures may be split across an employer's legal entities. Absence of a filing means none appears in our copy of the data, not that none exists.

Community outcomes

No reports yet — be the first to help the next applicant.

About the role

  • Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases.
  • The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for facioscapulohumeral muscular dystrophy (FSHD), Pompe disease and multiple DMD mutations.
  • Learn more at https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.

Requirements

  • Advanced scientific or business degree or equivalent experience desirable
  • Experience in vendor selection and overseeing studies being managed by a CRO
  • Demonstrated ability to problem solve and use clear judgment in relation to regulatory requirements, interactions with external parties, timelines, and complex clinical programs

Nice to have

  • Experience across several complex therapeutic areas
  • neuromuscular or muscle disease experience preferred.
  • Experience with rare disease and/or pediatric trials also preferred

Compensation

  • $165,000 - $200,000 USD

Company info

  • We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease.
  • At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities.

Visa & Work Authorization

  • Perform and document sponsor oversight activities for outsourced trial activities, including oversight of CRO performance, KPIs, KRIs, protocol deviations, quality events, risks, and CAPAs to ensure complianc

This listing is sourced directly from Dyne Therapeutics's careers page and normalized into a canonical job model.